preview

The 's Innate Immunity Of A Patient

Better Essays

Abstract:
TLRs are a family of evolutionarily preserved transmembrane proteins that differentiate well-preserved molecules on pathogens. TLR-9 plays a pivotal role in a host’s inborn and adaptive immunity. The latest research into boosting the innate immunity of a patient has caused the introduction of TLRs treatment to manage cancerous cells (Coussens & Werb, 2013). The mice breast cell line seasoned for breast cancer was found to express TLR-9 at both the protein and the mRNA levels. It is evident that TLR-9 signaling and pathways directly inhibit tumor growth or improve immunotherapy in patients suffering from prostate cancer. The stimulation of TLR-9 induces an NF-Kb-facilitated inflammation, described by an amplified expression of different cytokines and interleukins. TLR-9 acts as mediators for the stimulation of the host 's immune system to attack cancer-causing cells. TLR-9 is signaled for activity by CpG ODN.

Introduction:
According to Becker (2013), cancer is one of the principal sources of bereavement in our contemporary society. There are roughly 200 different types of cancer. A recent study conducted in 2012 reported that there were 15.1 million new cancer cases, more than 9 million cancer deaths and 33.7 million people living with cancer in 2013 worldwide (p. 23). Cancer cells have the ability to elude immune responses, thereby promoting the development of tumor phenotypes and pathways that bypass the immune cells. The role of the immune system in rebelling

Get Access